.jpg)
Credit: The White House
The White House has withdrawn the nomination of Heidi Overton, MD, one of President Trump’s senior domestic policy advisers, for commissioner of the Food and Drug Administration (FDA).
Sen. Bill Cassidy, MD, a Louisiana Republican, wrote on X last night that he was disappointed in that decision. A Senate health committee was scheduled to vote on her nomination today.
“The White House abandoned a viable confirmation path for Dr. Overton,” wrote Cassidy, who will leave the Senate after losing the Republican primary last spring.
The White House “said that this was because she did not have the votes to pass,” Cassidy wrote. “This was odd as I was having productive conversations with members. I believe she would have had the votes to pass out of committee and pass the full Senate. My conversations with her convinced me she would follow the science and push back against decisions that put Americans’ health at risk.”
Kyle Diamantas, JD, has been serving as the acting FDA commissioner since early May, when Marty Makary, MD, MPH, resigned from the position. Makary served in the role for just over a year.
Opposition from abortion opponents, MAHA leaders
In his post, Cassidy said that some senators wanted the White House to commit more strongly to anti-abortion policies.
“Pro-life Senators sought final assurances from the Administration regarding the Administration’s commitment to life issues,” Cassidy wrote. “The Administration withdrew Dr. Overton rather than make such commitments. Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats.”
Some leaders of the Make America Healthy Again (MAHA) movement, which includes critics of childhood vaccinations and chemical additives in food, have been critical of Overton.
In a post on X, the advocacy group MAHA Action wrote, “The White House clearly recognizes that we have a once in a lifetime opportunity to change the D.C. status quo, and that the next FDA commissioner must be aligned with the MAHA agenda.”